Martek Casts For CHD Reduction Claim For Fish Oils, Big Disclaimer For Fish
This article was originally published in The Tan Sheet
Executive Summary
Fish oil products and supplements containing omega-3 fatty acids would be exempt from lengthy disclaimers when using qualified coronary heart disease reduction claims, while fish would not, under a proposal submitted to FDA by Martek Biosciences
You may also be interested in...
Industry Qualifies Enthusiasm For Omega-3 Qualified Health Claim
FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend
Industry Qualifies Enthusiasm For Omega-3 Qualified Health Claim
FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend
Industry Qualifies Enthusiasm For Omega-3 Qualified Health Claim
FDA's qualified health claim linking omega-3 fatty acids to coronary heart disease too narrowly interprets the beneficial relationship, dietary supplement industry stakeholders contend